ELISABET: Epidemiological Study on the Relationship Between Respiratory Health and Air Pollution From Industrial Sources

Sponsor
University Hospital, Lille (Other)
Overall Status
Completed
CT.gov ID
NCT02490553
Collaborator
(none)
3,276
37

Study Details

Study Description

Brief Summary

The ELISABET STUDY is across sectional Survey on a representative sample of two urban area conduct on a representative sample. The main objective of the project is to compare the prevalence of the obstructive ventilatory disorders (OVD) in the Urban Community of Dunkirk touched by the industrial pollution in relation to the one recovered in the Urban Community of Lille (CUDL) less industrialized.

Condition or Disease Intervention/Treatment Phase
  • Other: heteroevaluation scale by a nurse or doctor

Detailed Description

Airflow obstruction include Pulmonary Disease, Chronic Obstruction and asthma. Identification of Airflow obstruction is through Functional Tests Lung. In the 1950s, high pollution levels were associated with increased mortality. Despite a reduction of air pollution, it has been established that pollution peaks have short-term effects on acute respiratory episodes. The Urban Community of Dunkirk (CUD) focuses many large pollutant emitters. The long term effects of industrial pollution on TVO are unknown.

The main objective of the project is to compare the prevalence of Airflow obstruction in the Urban Community of Dunkirk affected by industrial pollution compared to that found in the Urban Community of Lille (CUDL) less industrialized. Secondary objectives are: 1) To assess the relationship between air pollution from industrial and biological markers, particularly the plasma concentrations of heavy metals 2) To assess the prevalence of TVO general population in French populations 3) Establish a baseline epidemiological and biological bank.

Study Design

Study Type:
Observational
Actual Enrollment :
3276 participants
Time Perspective:
Cross-Sectional
Official Title:
ELISABET : EnquĂȘte LIttoral Souffle Air Biologie Environnement
Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Nov 1, 2013
Actual Study Completion Date :
Feb 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Dunkirk area

Representative sample of Dunkirk and the surrounding urban area (of ~200 000inhabitants).Dunkirk area is characterize by high emission of industrial air pollutant

Other: heteroevaluation scale by a nurse or doctor

Lille area

Representative sample of Lille and the surrounding urban area (of ~1 million inhabitants, the fourth urban area in France)

Other: heteroevaluation scale by a nurse or doctor

Outcome Measures

Primary Outcome Measures

  1. airway obstruction [during a the single visit scheduled (less than 3 hours in the morning)]

    Forced expiratory volume per second (FEV1) to forced vital capacity (FVC) ratio below 0.7. mesured by standardized spirometry Spirometry testing was performed mostly at home using Micro 6000 spirometers (Medisoft; Sorinnes, Belgium), according to the 2005 ATS/ERS guidelines. The spirometers were calibrated weekly. No bronchodilators were administered. For each participant, the spirometry test was repeated (up to seven times) until three acceptable, reproducible flow-volume loops were obtained, following the same guidelines. The greatest reproducible values of FEV1 and FVC were selected for the statistical analysis (regardless of whether these two values came from separate curves or from the same curve). All spirometry data were validated by an experienced, specialist physician.

Secondary Outcome Measures

  1. hypertension [during a the single visit scheduled (less than 3 hours in the morning)]

    Hypertension was defined as ongoing antihypertensive treatment, an Systolic blood pressure >=140 mmHg or a Diastolic Blood pressure >=90 mmHg

  2. dyslipidemia [during a the single visit scheduled (less than 3 hours in the morning)]

    Dyslipidemia was defined as ongoing cholesterol-lowering treatment or one or more abnormal fasting blood lipid values (total cholesterol 2.4 g/L, LDLcholesterol>=1.6 g/L, HDLcholesterol <0.4 g/L or blood triglycerides >=2 g/L)

  3. diabetes mellitus [during a the single visit scheduled (less than 3 hours in the morning)]

    Diabetes mellitus was defined as ongoing antidiabetes treatment (oral medication or insulin) or a fasting blood glucose (FBG) level >=1.26 g/L

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • had lived for at least 5 years in the same city or its surrounding urban area (either Lille or Dunkirk) in the northern of France

  • Agreed to participate and signed contentment

Exclusion Criteria:
  • The detainees

  • People under legal protection

  • Individuals unable to consent

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Hospital, Lille

Investigators

  • Principal Investigator: Luc Dauchet, PhD MD, CHRU Lille

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Lille
ClinicalTrials.gov Identifier:
NCT02490553
Other Study ID Numbers:
  • 2009_32/1003
  • 2010-A00065-34
First Posted:
Jul 7, 2015
Last Update Posted:
Jul 7, 2015
Last Verified:
Jul 1, 2015
Keywords provided by University Hospital, Lille
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 7, 2015